Increasing the Effectiveness of the Diabetes Prevention Program
NCT ID: NCT02008435
Last Updated: 2018-03-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
172 participants
INTERVENTIONAL
2013-04-30
2017-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Trial Comparing Two Approaches to Weight Loss
NCT02671110
Obesity Treatment Using an Internet-delivered Intervention Based on the Diabetes Prevention Program in Mexican Adults
NCT03629301
Evaluating a Small Change Approach to Preventing Long Term Weight Gain in Overweight and Obese Adults
NCT02027077
Efficacy of Different Behaviour Change Techniques in MyPlan 2.0
NCT03274271
Sharing Digital Self-Monitoring Data With Others to Enhance Long-Term Weight Loss
NCT05180448
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Enriched GLB
This arm aims to increase the effectiveness of the Group Lifestyle Balance (GLB) program by integrating habit formation techniques, namely if-then plans and their mental practice, into the program.
Enriched GLB
Habit formation techniques, namely if-then plans and their mental practice are being added to the standard Group Lifestyle Balance program.
Standard GLB
This arm is the standard Group Lifestyle Balance (GLB) program, which is the group version of the Diabetes Prevention Program developed by the NIH.
Standard GLB
This arm is the standard Group Lifestyle Balance program
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Enriched GLB
Habit formation techniques, namely if-then plans and their mental practice are being added to the standard Group Lifestyle Balance program.
Standard GLB
This arm is the standard Group Lifestyle Balance program
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* ages of 18 and 75
* overweight or obese (BMI 28-45 kg/m2)
* sedentary (\< 200 min/week of moderate or vigorous exercise)
* waist circumference of \>= 88cm for women and \>= 102cm for men
Exclusion Criteria
* taking the medication metformin (used for treating pre-diabetes or diabetes)
* having been pregnant in the past 6 months or planning on becoming pregnant in the next 2 years
* currently undergoing treatment for cancer
* using medication that affects body weight (e.g., loop diuretics)
* being unable to participate in regular moderate physical activity
* having severe uncontrolled hypertension (\> 190/100mm Hg)
* being unable to communicate in English or French
* being diagnosed with bulimia nervosa, currently active major depression, or other severe psychiatric disease (including dementia);
* suffering from a heart attack, stroke, or heart failure within the past 6 months
* experiencing excessive weight loss (more than 10 pounds or 4.54 kilograms) in the past 3 months
* currently participating in another weight loss program
* having had bariatric surgery in the past 2 years or plans on getting it in the near future
* planning on moving away from Montreal within the next year
* having another member of one's household enrolled in the program.
18 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
McGill University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Barbel Knauper
Associate Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Barbel Knauper, PhD
Role: PRINCIPAL_INVESTIGATOR
McGill University
Ilka Lowensteyn, PhD
Role: STUDY_DIRECTOR
McGill University
Lawrence Joseph, PhD
Role: STUDY_DIRECTOR
McGill University
Aleksandra Luszczynska, PhD
Role: STUDY_DIRECTOR
University of Colorado, Denver
Steven Grover, MD
Role: STUDY_DIRECTOR
McGill University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
McGill University
Montreal, Quebec, Canada
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Knauper B, Shireen H, Carriere K, Frayn M, Ivanova E, Xu Z, Lowensteyn I, Sadikaj G, Luszczynska A, Grover S; McGill CHIP Healthy Weight Program Investigators. The effects of if-then plans on weight loss: results of the 24-month follow-up of the McGill CHIP Healthy Weight Program randomized controlled trial. Trials. 2020 Jan 7;21(1):40. doi: 10.1186/s13063-019-4014-z.
Knauper B, Carriere K, Frayn M, Ivanova E, Xu Z, Ames-Bull A, Islam F, Lowensteyn I, Sadikaj G, Luszczynska A, Grover S; McGill CHIP Healthy Weight Program Investigators. The Effects of If-Then Plans on Weight Loss: Results of the McGill CHIP Healthy Weight Program Randomized Controlled Trial. Obesity (Silver Spring). 2018 Aug;26(8):1285-1295. doi: 10.1002/oby.22226. Epub 2018 Jun 28.
Knauper B, Ivanova E, Xu Z, Chamandy M, Lowensteyn I, Joseph L, Luszczynska A, Grover S. Increasing the effectiveness of the Diabetes Prevention Program through if-then plans: study protocol for the randomized controlled trial of the McGill CHIP Healthy Weight Program. BMC Public Health. 2014 May 18;14:470. doi: 10.1186/1471-2458-14-470.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MOP-123242
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.